Lawford H G, Rousseau J D
Department of Biochemistry, University of Toronto, Ontario, Canada.
Appl Biochem Biotechnol. 1996 Spring;57-58:293-305. doi: 10.1007/BF02941709.
To be economic and to be compatible with modern continuous bioconversion systems, it is imperative that the process organism exhibits an extremely high degree of stability. In the case of ethanol production from lignocellulosic biomass, functional stability of the potential process biocatalyst can be assessed in terms of the capacity to sustain high-performance fermentation during the continuous fermentation of biomass-derived sugars. This investigation employed glucose- or xylose-limited chemostat culture to examine the functional stability of two patented, genetically engineered E. coli-namely E. coli B (ATCC 11303) carrying the Zymomonas genes for pyruvate decarboxylase and alcohol dehydrogenase II on a multicopy plasmid pLOI297 and a chromosomal pet integrant of strain 11303, designated as strain KO11. Both recombinants carry markers for antibiotic resistance and have been reported to exhibit genetic stability in the absence of antibiotic selection. Chemostats were fed with Luria broth (LB) (with 25 g/L sugar) at a dilution rate of 0.14 and 0.07/h when the feed medium was glucose-LB and xylose-LB, respectively. They pH was controlled at 6.3. With glucose, both recombinants exhibited a rapid loss of ethanologenicity even when selection pressure was imposed by the inclusion of antibiotics in the feed medium. With strain KO11, increasing the concentration of chloramphenicol from 40 to 300 mg/L, resulted in a retardation in the rate of loss of ethanologenicity, but it did not prevent it. Under xylose limitation, the plasmid-bearing recombinant appeared to be stabilized by antibiotics, but this did not reflect genetic stability, since the slower-growing revertant was washed out at a dilution rate of 0.07/h. With both recombinants, interpretation of functional stability with xylose was complicated by the inherent ethanologenicity associated with the host culture. Based on an average cost for large bulk quantities of antibiotics at $55/kg and an amendment level of 40 g/m3, the estimated economic impact regarding the potential requirement for operational stabilization by antibiotics in a plant operating in batch mode varied from a maximum of 29 cents/gal of E95 ethanol for antibiotic amendment of all fermentation media to a minimum of 0.45 cents/gal where antibiotics were used exclusively for the preparation of the inocula for every fourth batch fermentation cycle. The high degree of instability observed in these continuous fermentations does not auger well for the proposed potential industrial utility of these patented, genetically engineered constructs for the production of fuel ethanol from biomass and wastes.
为了实现经济可行性并与现代连续生物转化系统兼容,至关重要的是,生产菌株要表现出极高的稳定性。以木质纤维素生物质生产乙醇为例,潜在生产生物催化剂的功能稳定性可以通过在生物质衍生糖的连续发酵过程中维持高性能发酵的能力来评估。本研究采用葡萄糖或木糖限制的恒化器培养,以检验两种获得专利的基因工程大肠杆菌的功能稳定性,即携带丙酮酸脱羧酶和乙醇脱氢酶II的运动发酵单胞菌基因的大肠杆菌B(ATCC 11303),该基因位于多拷贝质粒pLOI297上,以及11303菌株的染色体pet整合体,命名为KO11菌株。两种重组体都带有抗生素抗性标记,并且据报道在没有抗生素选择的情况下表现出遗传稳定性。当进料培养基分别为葡萄糖-LB和木糖-LB时,以0.14和0.07/h的稀释率向恒化器中加入Luria肉汤(LB)(含25 g/L糖)。将pH控制在6.3。对于葡萄糖,即使在进料培养基中加入抗生素施加选择压力,两种重组体的产乙醇能力也迅速丧失。对于KO11菌株,将氯霉素浓度从40 mg/L提高到300 mg/L,导致产乙醇能力丧失速率减缓,但并不能阻止其丧失。在木糖限制条件下,携带质粒的重组体似乎通过抗生素得以稳定,但这并不反映遗传稳定性,因为生长较慢的回复突变体在0.07/h的稀释率下被冲洗掉。对于两种重组体,由于宿主培养物固有的产乙醇能力,对木糖功能稳定性的解释变得复杂。基于大批量抗生素的平均成本为55美元/kg以及添加水平为40 g/m3,在分批模式运行的工厂中,关于抗生素用于操作稳定化的潜在需求的估计经济影响从所有发酵培养基添加抗生素时每加仑E95乙醇最高29美分,到仅在每第四个分批发酵周期用于制备接种物时最低0.45美分不等。在这些连续发酵中观察到的高度不稳定性对于这些获得专利的基因工程构建体用于从生物质和废物生产燃料乙醇的潜在工业应用而言并非好兆头。